Ownership history in Spire Wealth Management · 4 quarters on record
This page tracks every 13F SEC filing in which Spire Wealth Management reported a position in CARTESIAN THERAPEUTICS INC (RNAC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 50 | — | 0% | 0.00% | $511 | $10.22 |
| 2025 Q2 | UNCHANGED | 50 | — | 0% | 0.00% | $520 | $10.39 |
| 2025 Q1 | UNCHANGED | 50 | — | 0% | 0.00% | $659 | $13.18 |
| 2024 Q4 | INITIATED | 50 | — | — | 0.00% | $896 | $17.91 |
As of 2025 Q4 — sorted by position size